Portage Biotech (NASDAQ:ATON) Trading Up 6.3% – Here’s What Happened

Portage Biotech Inc. (NASDAQ:ATON)’s share price was up 6.3% during trading on Monday . The stock traded as high as $0.3290 and last traded at $0.3290. Approximately 875,159 shares traded hands during mid-day trading, a decline of 3% from the average daily volume of 906,633 shares. The stock had previously closed at $0.3095.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ATON shares. Weiss Ratings started coverage on Portage Biotech in a research note on Monday, January 26th. They set a “sell (e+)” rating on the stock. HC Wainwright started coverage on Portage Biotech in a research note on Tuesday, February 24th. They set a “buy” rating and a $2.00 target price on the stock. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $2.00.

Portage Biotech Stock Performance

The stock has a 50 day moving average price of $0.40. The stock has a market capitalization of $7.71 million, a PE ratio of -0.04 and a beta of 0.49.

Portage Biotech (NASDAQ:ATON) last posted its earnings results on Wednesday, January 21st. The company reported ($4.13) earnings per share (EPS) for the quarter.

About Portage Biotech

Portage Biotech (NASDAQ:ATON) is a biotechnology company focused on acquiring, developing and advancing therapeutic candidates and platform technologies. The company concentrates its development efforts primarily in areas such as oncology, immunology/inflammation and infectious disease, seeking to move programs from discovery and preclinical stages into clinical development through subsidiary companies and collaborative arrangements.

Portage structures its operations to support a diversified pipeline, advancing both small molecules and biologics by funding preclinical research, conducting clinical trials, and managing regulatory interactions.